One of the most perplexing aspects of Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC), is how symptoms can persist for months or even years after the initial infection has cleared. Fatigue, brain fog, shortness of breath, muscle pain, and dysautonomia are just a few hallmark features. But what's driving this prolonged dysfunction? Increasing research is pointing to several overlapping biological mechanisms, including the persistence of the SARS-CoV-2 spike protein, chronic immune activation, and pre-existing or co-occurring environmental and infectious stressors. (1)
The SARS-CoV-2 virus enters human cells primarily by binding its spike protein to the ACE2 (angiotensin-converting enzyme 2) receptor, which is abundantly expressed in the lungs, heart, gut, kidneys, and brain. While the acute infection may resolve, studies have demonstrated that fragments of the spike protein, sometimes intact, can persist in circulation for weeks to months post-infection. (2)
When the spike protein binds to ACE2, it can dysregulate this enzyme's normal anti-inflammatory role in the renin-angiotensin system (RAS), tipping the balance toward a pro-inflammatory state. The result? A cascade of endothelial dysfunction, oxidative stress, and tissue injury, particularly in vulnerable organ systems like the brain, cardiovascular system, and gut. (3)
Even after viral clearance, the immune system may remain “stuck” in overdrive. This can be measured, in part, through inflammatory markers such as cytokines, chemokines, and complement proteins. One such marker, complement C4a, is often elevated in patients with chronic inflammatory response syndrome (CIRS) and has also been noted in subsets of Long Haulers. Elevated C4a reflects ongoing complement activation, an immune cascade designed to protect against pathogens, but which can become pathological when persistently engaged. (4)
This kind of immune dysregulation creates a milieu where the body is constantly fighting perceived or residual threats, often leading to mitochondrial dysfunction, mast cell activation, impaired detoxification, and worsening neurologic and cognitive symptoms. The immune system, in effect, becomes the problem, not just the solution.
One of the most compelling researchers in this field is Dr. Bruce Patterson, a former Stanford virologist whose team developed a specialized Long COVID cytokine panel. Through his company, IncellDx, and Radiance Diagnostics, Dr. Patterson identified a distinct inflammatory signature in Long Haulers, including persistently elevated levels of cytokines such as IL-6, IL-10, CCL5 (RANTES), and VEGF, even months after initial infection. His research suggests that non-classical monocytes harboring spike protein fragments continue to circulate, perpetuating immune activation. By mapping this cytokine profile, Patterson’s work allows for targeted immunomodulatory therapies aimed at resetting immune balance, often using repurposed medications like maraviroc and statins based on individual cytokine expression. His contributions offer both validation for suffering patients and a data-driven framework for more precise, personalized treatment.
At our clinic, we approach Long COVID not just as a lingering virus but as a complex chronic illness, one that often overlays and amplifies pre-existing or latent conditions. In our experience, many Long Haulers also show signs of:
These coexisting stressors can be “silent amplifiers,” keeping the immune system in a chronic danger response state, often described in the literature as the Cell Danger Response (CDR). Until these factors are identified and addressed, the immune system cannot fully downshift into a healing phase.
Effective treatment of Long COVID must go beyond symptom suppression. It involves identifying and removing the ongoing triggers of inflammation, restoring immune balance, and supporting mitochondrial and neurologic repair. Strategies may include:
Ultimately, the question is not only what happened during the acute phase of COVID-19, but what else was already happening under the surface that COVID exposed or exacerbated.
Long Haulers aren’t imagining their symptoms. The science increasingly confirms what patients have long known: recovery requires a personalized, root-cause approach, one that integrates virology, immunology, toxicology, and systems medicine.
Resources:
